NP / PA
Addea-Amoako, Liselotte
Addea-Amoako, Liselotte was paid $278K by Medicaid between Dec 2020 and Aug 2024, across 13 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 46% of everything it billed.
33Billing provider infoADDEA-AMOAKO, LISELOTTE
MANSFIELD, TX 76063
MANSFIELD, TX 76063
33aNPI1518208784assigned 03/12/2013
33bProvider typeFamily Nurse Practitioner
28Total paid$278K
24GClaims6,175
24DCodes billed13
24AFirst – last monthDec 2020 – Aug 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Texas
Rank by total paid#45 of 344
Median peer was paid$14K
This provider vs. median20×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 40 | $1K | |
| 2021 | 828 | $27K | |
| 2022 | 1,758 | $79K | |
| 2023 | 2,744 | $123K | |
| 2024incomplete | 805 | $48K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 46% | 3,044 | 2,489 | $128K |
| 99091 | 28% | 514 | 493 | $77K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.3% | 515 | 461 | $23K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 5.1% | 115 | 103 | $14K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.5% | 1,013 | 455 | $13K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.3% | 156 | 153 | $9K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.3% | 512 | 453 | $6K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.7% | 173 | 145 | $5K |
| 99385 | <1% | 15 | 15 | $1K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 14 | 14 | $746.67 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 12 | 12 | $91.70 |
| 36415 | Collection of venous blood by venipuncture | 0% | 63 | 49 | $0.00 |
1 more codes
| 3117F | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.